We are live on ! Find out more
NVCR icon

NovoCure
NVCR

238 hedge funds and large institutions have $1.24B invested in NovoCure in 2025 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 100 increasing their positions, 61 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more call options, than puts

Call options by funds: $16.7M | Put options by funds: $5.74M

64% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 61

10% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 40

3.34% more ownership

Funds ownership: 82.04% → 85.38% (+3.3%)

4% more capital invested

Capital invested by funds: $1.19B → $1.24B (+$50.9M)

2% less funds holding

Funds holding: 244 → 238 (-6)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
238
Holders Change
-6
Holders Change %
-2.46%
% of All Funds
2.89%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
44
Increased
100
Reduced
61
Closed
40
Calls
$16.7M
Puts
$5.74M
Net Calls
+$11M
Net Calls Change
-$5M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$53.3M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$14.4M
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$11.9M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$10.1M
5
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$7.38M

Top Sellers

1
Capital World Investors
Capital World Investors
California
-$25.8M
2
SCM
Soleus Capital Management
Connecticut
-$14.3M
3
Marshall Wace
Marshall Wace
United Kingdom
-$13.4M
4
UBS AM
UBS AM
Illinois
-$12.4M
5
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$12.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
126
PDT Partners
New York
$288K +$286K +22,252 New
AAP
127
Arax Advisory Partners
Colorado
$284K -$164K -12,813 -37%
VanEck Associates
128
VanEck Associates
New York
$279K +$4.67K +364 +2%
TSS
129
Two Sigma Securities
New York
$270K +$268K +20,852 New
Carson Wealth (CWM LLC)
130
Carson Wealth (CWM LLC)
Nebraska
$269K +$118K +9,213 +80%
Mariner
131
Mariner
Kansas
$264K -$40.8K -3,182 -14%
KCP
132
Kera Capital Partners
California
$244K +$116K +9,015 +84%
VOYA Investment Management
133
VOYA Investment Management
Georgia
$241K – – –
CUAMC
134
China Universal Asset Management Company
China
$236K -$17.3K -1,350 -7%
Holocene Advisors
135
Holocene Advisors
New York
$236K +$234K +18,229 New
SC
136
Syon Capital
California
$226K +$48.6K +3,788 +28%
LPL Financial
137
LPL Financial
California
$212K +$27.6K +2,153 +15%
I
138
InceptionR
California
$208K -$16.9K -1,315 -8%
Pictet Asset Management
139
Pictet Asset Management
Switzerland
$207K – – –
Creative Planning
140
Creative Planning
Kansas
$201K -$58K -4,518 -23%
M1FG
141
Mach-1 Financial Group
Arkansas
$189K +$188K +14,646 New
PCM
142
Polymer Capital Management
New York
$176K +$175K +13,625 New
HIP
143
HUB Investment Partners
Texas
$175K +$174K +13,540 New
Royal Bank of Canada
144
Royal Bank of Canada
Ontario, Canada
$166K +$21.4K +1,667 +15%
WG
145
Winton Group
United Kingdom
$166K +$164K +12,800 New
ICP
146
Interchange Capital Partners
Pennsylvania
$153K +$152K +11,851 New
Public Employees Retirement Association of Colorado
147
Public Employees Retirement Association of Colorado
Colorado
$153K – – –
Walleye Capital
148
Walleye Capital
New York
$151K -$2.63M -205,117 -95%
Victory Capital Management
149
Victory Capital Management
Texas
$149K +$1.48K +115 +1%
TC
150
TwinBeech Capital
New York
$146K +$145K +11,330 New
4 5
6
7 8

NVCR Hedge Fund Activity: Q4 2025 in Review

238 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q4 2025, worth a combined $1.24B — up 4.3% from $1.19B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new NVCR positions and 40 closed out — a net gain of 4 holders — while 100 added to existing stakes and 61 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $53.3M. The largest seller was Capital World Investors, exiting entirely with an estimated $25.8M sold.

  • 238 institutional investors held NovoCure (NVCR) as of Q4 2025, down from 244 in Q3 2025.
  • Funds reported $1.24B of NovoCure stock for Q4 2025, up 4.3% quarter-over-quarter.
  • 44 funds opened new NovoCure positions in Q4 2025 and 40 closed out, a net change of +4 holders.
  • The largest NovoCure buyer in Q4 2025 was Morgan Stanley, an estimated $53.3M added.
  • The largest NovoCure seller in Q4 2025 was Capital World Investors, an estimated $25.8M sold.

Based on aggregated 13F filings for Q4 2025.